Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
For the six months, sales was INR 1,691.7 million compared to INR 1,285.65 million a year ago. Revenue was INR 1,765.92 million compared to INR 1,298.71 million a year ago. Net income was INR 296.33 million compared to INR 227.68 million a year ago. Basic earnings per share from continuing operations was INR 29.63 compared to INR 22.77 a year ago. Diluted earnings per share from continuing operations was INR 29.63 compared to INR 22.77 a year ago.